Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Aug;45(4):130-131.
doi: 10.18773/austprescr.2022.032. Epub 2022 Aug 1.

Severe adverse drug reaction to allopurinol

Grace Lucas  1   2   3 , Luke Droney  1   2   3
Affiliations
Case Reports

Severe adverse drug reaction to allopurinol

Grace Lucas et al. Aust Prescr. 2022 Aug.
No abstract available

Keywords: HLA antigens; adverse drug reaction; allopurinol; drug reaction with eosinophilia and systemic symptoms.

PubMed Disclaimer

References

    1. Martínez-Cabriales SA, Rodríguez-Bolaños F, Shear NH. Drug reaction with eosinophilia and systemic symptoms (DReSS): how far have we come? Am J Clin Dermatol 2019;20:217-36. 10.1007/s40257-018-00416-4 - DOI - PubMed
    1. White KD, Chung WH, Hung SI, Mallal S, Phillips EJ. Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response. J Allergy Clin Immunol 2015;136:219-34. 10.1016/j.jaci.2015.05.050 - DOI - PMC - PubMed
    1. Jutkowitz E, Dubreuil M, Lu N, Kuntz KM, Choi HK. The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States. Semin Arthritis Rheum 2017;46:594-600. 10.1016/j.semarthrit.2016.10.009 - DOI - PMC - PubMed
    1. FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, et al. 2020 American College of Rheumatology guideline for the management of gout [Errata in Arthritis Care Res (Hoboken) 2020;72:1187 and Arthritis Care Res (Hoboken) 2021;73:458]. Arthritis Care Res (Hoboken) 2020;72:744-60. 10.1002/acr.24180 - DOI - PMC - PubMed

FURTHER READING

    1. Copaescu AM, Trublano JA. The assessment of severe cutaneous adverse drug reactions. Aust Prescr 2022;45:43-8. 10.18773/austprescr.2022.010 - DOI - PMC - PubMed

Publication types

LinkOut - more resources